MINERVA SURGICAL, INC.

$1.98 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About MINERVA SURGICAL, INC.

Minerva Surgical, Inc. is a commercial-stage medical technology company. The Company focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. It offers a suite of products for the treatment of structural and non-structural causes of abnormal uterine bleeding (AUB) in uterine anatomies. Its products are alternatives to hysterectomy. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a range of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices. The Company's products include Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES and Genesys HTA is an endometrial ablation device. Symphion is a minimally invasive uterine tissue removal system. Resectr is a handheld surgical instrument.

Stock Analysis

last close $2.14
1-mo return -8.5%
3-mo return 22.3%
avg daily vol. 46.14T
52-week high 10.37
52-week low 1.61
market cap. $62M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $51M
inst own. 77.2%
baraka

Subscribe now for daily local and international financial news

Subscribe